CYTOKINETICS INC — Director's Dealing 2014

Jan 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-01-02

Reporting Person: PARSHALL B LYNNE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-02	Non-Qualified Stock Option (right to buy)	$6.72	A	6510	Acquired	2024-01-02	Common Stock (6510)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 6,510 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2015.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of 50% of an annual retainer of $35,000.